The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
4D MOLECULAR THERAPEUTICS INC COM 35104E100   1,800,704 104,753 SH   SOLE   104,753 0 0
AADI BIOSCIENCES INC COM 00032Q104   13,389,670 1,849,402 SH   SOLE   1,849,402 0 0
ACLARIS THERAPEUTICS COM 00461U105   985,686 121,840 SH   SOLE   121,840 0 0
ALKERMES PLC SHS G01767105   893,313 31,689 SH   SOLE   31,689 0 0
APELLIS PHARMACEUTICALS INC COM 03753U106   19,161,380 290,500 SH   SOLE   290,500 0 0
ARGEN SE SPONSORED ADR 04016X101   3,574,533 9,594 SH   SOLE   9,594 0 0
BELLUS HEALTH INC COM NEW 07987C204   4,554,000 632,500 SH   SOLE   632,500 0 0
CELLDEX THERAPEUTICS INC COM NEW 15117B202   4,371,570 121,500 SH   SOLE   121,500 0 0
CELLDEX THERAPEUTICS INC COM NEW 99D2DH6V9   3,598,000 1,000 SH Put SOLE   1,000 0 0
CYMABAY THERAPEUTICS INC. COMMON STOCK COM 23257D103   7,660,520 878,500 SH   SOLE   878,500 0 0
ENLIVEN THERAPEUTICS INC COM 29337E102   678,440 30,979 SH   SOLE   30,979 0 0
EYEPOINT PHARMACEUTICALS INC COM NEW 30233G209   891,984 303,396 SH   SOLE   303,396 0 0
GH RESEARCH PLC ORDINARY SHARES G3855L106   1,943,568 243,250 SH   SOLE   243,250 0 0
HILLEVAX INC COM 43157M102   110,156 6,664 SH   SOLE   6,664 0 0
HORIZON THERAPEUTICS PLC SHS G46188101   654,840 6,000 SH   SOLE   6,000 0 0
IOVANCE BIOTHERAPEUTICS INC COM 462260100   938,734 153,639 SH   SOLE   153,639 0 0
IVERIC BIO INC COM 99D2WLPZ9   3,649,500 1,500 SH Call SOLE   1,500 0 0
IVERIC BIO INC COM 46583P102   6,824,565 280,500 SH   SOLE   280,500 0 0
KEROS THERAPEUTICS INC COM 492327101   152,653 3,575 SH   SOLE   3,575 0 0
KINNATE BIOPHARMA INC COM 49705R105   31,250 5,000 SH   SOLE   5,000 0 0
KURA ONCOLOGY INC. COMMON STOCK COM 50127T109   6,913,093 565,257 SH   SOLE   565,257 0 0
MERSANA THERAPEUTICS INC COM 59045L106   246,600 60,000 SH   SOLE   60,000 0 0
NUVATION BIO INC *W EXP 07/07/2027 67080N119   10,900 90,832 SH   SOLE   90,832 0 0
PMV PHARMACEUTICALS INC COM 69353Y103   736,827 154,471 SH   SOLE   154,471 0 0
REZOLUTE INC COM NEW 76200L309   703,112 366,204 SH   SOLE   366,204 0 0
ROCKET PHARMACEUTICALS INC COM 77313F106   5,104,740 298,000 SH   SOLE   298,000 0 0
SAREPTA TEHRAPEUTICS INC COM 803607100   4,516,689 32,770 SH   SOLE   32,770 0 0
SAVARA INC COM 805111101   388,110 199,031 SH   SOLE   199,031 0 0
SYNDAX PHARMACEUTICALS INC COM 87164F105   6,969,600 330,000 SH   SOLE   330,000 0 0
TERNS PHARMACEUTICALS INC COM 880881107   13,015,819 1,099,309 SH   SOLE   1,099,309 0 0
UNITED THERAPEUTICS CORP DEL COM 91307C102   5,263,060 23,500 SH   SOLE   23,500 0 0
VAXCYTE INC COM 92243G108   4,516,340 120,500 SH   SOLE   120,500 0 0
VENTYX BIOSCIENCES INC COM 92332V107   6,984,750 208,500 SH   SOLE   208,500 0 0
VIKING THERAPEUTICS INC COM 92686J106   233,100 14,000 SH   SOLE   14,000 0 0
VIRIDIAN THERAPEUTICS INC COM 92790C104   4,273,920 168,000 SH   SOLE   168,000 0 0